The back office of a medical practice is like the offensive line on a football team: It does the job no one else wants to do.

On this episode of The Corner Series, host Geoff Cockrell is joined by MedHQ President Erik Miller to discuss how outside back-office support for areas such as HR, accounting and credentialing can improve and streamline a medical practice.

Tune in as Erik discusses how smaller practices and full health systems can benefit from outside back-office support, the “frenemy” relationship between ambulatory surgery centers and large health systems, and how artificial intelligence can benefit the medical community.

SAIGroup has announced it has acquired Get Well.

Get Well, founded in 2000 and based in Bethesda, Maryland, is a provider of patient engagement technology and services.

SAIGroup, founded in 2017 and based in Palo Alto, California, is a private equity firm focused on acquiring and growing enterprise artificial intelligence companies that operate in the healthcare/life sciences and commercial industries.

Terms of the acquisition were not disclosed.

FFL Partners has announced it has invested in Medicus IT.

Medicus, founded in 2004 and based in Alpharetta, Georgia, is a healthcare-focused IT managed services provider.

FFL, based in San Francisco, invests in middle market companies within healthcare and business services. Founded in 1997, the firm generally commits $50 million to $200 million to individual transactions and purses control and minority stake transactions.

Terms of the investment were not disclosed.

Avesi Partners has announced the closing of a new fund at $1.35 billion.

The fund, Avesi Partners Fund II, was oversubscribed and closed at its hard cap.

Avesi, based in Stamford, Conn., is a private equity firm focused on healthcare services, healthcare technology and business services. Founded in 2021, the firm generally targets lower middle market companies with around $10 million to $30 million of EBITDA.

Lee Equity Partners has announced the closing of a new fund with total capital commitments of approximately $1.3 billion.

The fund, Lee Equity Partners Fund IV, was oversubscribed and exceeded its $1.0 billion target.

The fund will be used to continue Lee Equity’s strategy of investing in companies in healthcare and financial services.

Lee Equity is a New York-based private equity firm that focuses on control buyouts and growth capital financings in the middle market. Founded in 2006, the firm prefers to make more substantial investments in companies with EBITDA between $10 million and $30 million.

Argosy Healthcare Partners (AHP) has announced the recapitalization of Connect Life Sciences (CLS).

CLS, founded in 2020 and based in Orlando, Florida, provides recruitment services to pharmaceutical, biotechnology and medical device companies.

AHP, based in Wayne, Pa., is a lower middle market private equity investor focused exclusively on healthcare. A division of Argosy Capital, AHP typically pursues majority control transactions in U.S.-based, founder-owned healthcare businesses with $1 million to $3 million of EBITDA.

Terms of the investment were not disclosed.

Triton Pacific Healthcare Partners has announced the closing of its sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. 

BioMatrix, founded in 2001 and based in Plantation, Florida, is a provider of specialty infusion services in the United States. 

Triton Pacific Healthcare Partners is the healthcare division of Triton Pacific Capital Partners. Triton Pacific Capital Partners, founded in 2001 and based in Los Angeles, typically pursues controlling equity but considers minority positions in small to middle market companies within healthcare and several other industries. 

Frazier, based in Seattle, is a provider of private equity capital to healthcare companies. The firm, founded in 1991, prefers to make more substantial investments from a dollars perspective and pursues a wide range of investment types, including company creation and venture capital to buyouts of profitable lower-middle market companies.

Terms of the transaction were not disclosed.

Altaris has announced it will acquire Sharecare (NASDAQ: SHCR) for $1.43 in cash per share, or about $518 million.

Sharecare, founded in 2010 and based in Atlanta, is a digital health company that provides technology and services across the healthcare ecosystem through three business channels: enterprise, provider and life sciences.

Altaris, based in New York, seeks control and minority equity investments exclusively in healthcare. Founded in 2002, the firm targets companies within the life sciences/pharmaceutical, provider services and non-reimbursement healthcare industries. Altaris is flexible in its investment sizes.

Following completion of the acquisition, Sharecare will become a privately held company.

McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity and finance. We are hopeful that this series will serve to inspire other women to pursue their careers in private equity and finance in a way that best challenges and motivates them, which these impressive women have all done. We are pleased to feature Dianna Carr-Coletta of PGIM Private Capital. Access her profile.

To recommend a woman for a future interview, email WPEF@mcguirewoods.com.

H.I.G. Capital has announced the acquisition of Health-E Commerce (HEC).

HEC, founded in 2010 and based in Dallas, is an e-commerce retailer of flexible spending account (FSA) and health savings account (HSA) eligible products and services. HEC is the parent brand to FSA Store and HSA Store.

H.I.G. Capital, based in Miami, pursues a wide range of investments in healthcare and many other industries. Founded in 1993, the firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.

Terms of the acquisition were not disclosed.